A recent study by global market research entity, ResearchAndMarkets.com, indicates that the use of ethylene oxide (often referred to as EtO2) for sterilization services is set to chalk up significant growth over the next decade. The market, it is anticipated, will burgeon to an impressive USD 11.17 billion by 2032. The cause for this uptick illustrates the dire necessity of substantial infection management, especially in the realm of healthcare services.
One of the major contributors to this ascending trend is the integral role of sterilization in infection prevention. A whopping 50% of medical implements in need of sterilization in the United States—amounting to nearly 20 billion tools per annum—undergo EtO2 sterilization. This method, recognized for its efficacy in prohibiting the proliferation of destructive microorganisms, is crucial in upkeeping the health security of patients and medical professionals. The U.S. FDA’s ongoing observation and management of sterilization techniques further the swell in market expansion.
Ethylene oxide sterilization covers a vast spectrum of applications, paramount in countless hospital, medical occupation, and lab procedure protocols. Being engaged to sterilize around 50% of all medical devices, the sterilization method is pivotal in restricting the spread of infectious diseases. Companies active in the medical equipment manufacturing sector continue to develop cutting-edge technologies and services to keep ahead of global concerns. For instance, PAMA’s 2023 launch of a novel ethylene oxide sterilization solution reflects the systematic industrial progression that fuels the expansion of the market.
The detrimental effects of hospital-related infections make the case for the increasing demand for astute sterilization methods. With changing clinical practices, spiking patient severity, extended hospital stays, and more frequent use of medical apparatus, the concern continues to escalate. Current figures from the CDC indicate that Healthcare-Associated Infections (HAIs) account for up to 1.7 million infections. To combat HAIs, high priority is given to the sterilization of surgical tools, biopsy forceps, implanted devices, and other medical hardware. This underlines the global surge in demand for ethylene oxide sterilization, which, in turn, reinforces market growth.
Key participants in the global market include 3M, Getinge, Sterigenics (A Sotera Company), Ionisos, Andersen Sterilizers, Cosmed Group, and Sterility Equipment. In 2022, the hospital segment dominated the global market, propelled by a rising number of surgeries and increased governmental support to mitigate HAIs. In the coming years, North America is projected to take the lead, driven by an upswing in healthcare expenditure, a rise in chronic diseases prevalence, and an uptick in the adoption of advanced sterilization services and products.